R&D Site in Shanghai

A fully equipped State-of-the-art laboratory facility 

Our headquarters are based in Zhangjiang, Pudong, Shanghai. The Shanghai site has a state-of-the-art laboratory facility that hosts both our discovery unit and the CMC research unit (cell line and analytical development). There are also large open-office spaces hosting the R&D organization, the CMC department and the operation teams. Site address: Suites 802, 505, 702, West Tower, 88 Shangke Road, Pudong New District, Shanghai, China.

Beijing Site

Home to I-Mab’s Regulatory Affairs team

Our Beijing site is located in Changchunjie, Xicheng, Beijing in the vicinity of the National Medical Product Administration and is home to I-Mab’s regulatory affairs team headed by Tiffany Liang. Site address: Room 15A02, Dacheng Mansion, No.127, Xuanwumen West Avenue, XiCheng District, China.

US Site

Our Global Clinical Development Platform

Our US site is located at Suite 710, 9801 Washingtonian Blvd, Gaithersburg, Maryland. Close to the US FDA, the area has a unique blend of biotech and academia, with the National Institutes of Health, the National Cancer Institute and Johns Hopkins University all nearby. Our US site is dedicated to the clinical development of I-Mab’s global portfolios. Two clinical development strategies have been put in place: one is to work with Center of Excellence Phase 1 units to expedite clinical development, and the other is to co-develop with other biotech/pharma companies in the US. In conjunction with global Business Development, we will continue to seek collaboration and partnering opportunities. Our US site is an integral part of our R&D and is critical for our global development strategy. Currently we are expanding the US clinical team, and also setting up a translational medicine group with a biomarker laboratory in the country. 

Hong Kong Office

A Regional Hub for Capital Markets and Investor Relations Activities

Our Hong Kong office is located at Suite 5105, The Center, 99 Queen’s Road Central. Strategically, Hong Kong office serves as a regional hub to engage with rich network of investors, capital market practitioners and potential partners about I-Mab’s mission to bring transformational and innovative medicines to patients across the globe. The establishment allows us to maximize the fund-raising potential and capital market connectivity whilst rapidly growing to become one of the world’s most innovative biotech companies.


Copyright I-MAB Biopharma Co., Ltd. all rights reserved 2019 沪ICP备17007960号-1